Analisis Strategi Persaingan PT Kalbe Farma Tbk

https://doi.org/10.22146/jmpf.85958

Jessica Aryanti(1*), Umi Kaltum(2)

(1) Fakultas Ekonomi dan Bisnis, Universitas Padjadjaran, Bandung
(2) Fakultas Ekonomi dan Bisnis, Universitas Padjadjaran, Bandung
(*) Corresponding Author

Abstract


Competitive strategy analysis can be fundamental for responding to external conditions and increasing internal capabilities in generating a company’s competitive advantage. The purpose of this research is to determine the company's position in the industry as a basis for selecting alternative strategies so the company can strengthen its competitiveness and overcome its weaknesses in facing competitors. The methodology is descriptive qualitative research. Observation is done by data obtained from secondary sources. The analysis carried out includes: The Input Stage with Competitive Profile Matrix; The Matching Stage with Boston Consulting Group (BCG) Matrix and the Grand Strategy Matrix based on competitive analysis according to Porter's Five (Plus One) Forces; The Decision Stage with the Quantitative Strategic Planning Matrix (QSPM). Justification was carried out based on a Forum Group Discussion with several experts using the Delphi Method. The result shows that there is a change in competitive conditions, thus the market leader company, Kalbe Farma, needs to make strategic adjustments. In conclusion, the results of strategy alternatives’ formulation through BCG Matrix and Grand Strategy, as well as the selection of strategies using the QSPM show that the priority strategies for Kalbe Farma, respectively sorted from the most recommended are Market Penetration, Market Development, and Product Development.


Keywords


Analisis Strategi Persaingan; BCG Matrix; Grand Strategy; QSPM

Full Text:

PDF


References

  1. Wheelen TL. Strategic Management and Business Policy: Globalization, Innovation, and Sustainability. Fifteenth edition. Pearson; 2018.
  2. Amine Abdelli ME, Chemma N, Ahlem S, Maliki SB, Singh G. Competitive Advantage, Strategy and Innovation in Africa: Issues and Applications.; 2023:192. doi:10.4324/9781003306405
  3. Kementerian Perindustrian Republik Indonesia. Buku Analisis Pembangunan Industri: Membangun Kemandirian Industri Farmasi Nasional.; 2021.
  4. Yu TH, Mei YY, Tseng YJ. Biopharma innovation trends during COVID-19 and beyond: an evidence from global partnerships and fundraising activities, 2011-2022. Globalization and Health. 2023;19(1). doi:10.1186/s12992-023-00953-6
  5. Laermann-Nguyen U, Backfisch M. Innovation crisis in the pharmaceutical industry? A survey. SN Bus Econ. 2021;1(12):164. doi:10.1007/s43546-021-00163-5
  6. Lew I. Leveraging the pharmacy executive beyond the pharmacy enterprise: Opportunities for advocacy, senior leadership integration, and strategic positioning. American Journal of Health-System Pharmacy. 2022;79(6):405-406. doi:10.1093/ajhp/zxab402
  7. Haidar A. Intip 5 Perusahaan Farmasi Terbesar Indonesia Terbaru 2022. IDX Channel. 2022.
  8. PT Kalbe Farma Tbk. Laporan Tahunan 2022 Annual Report KLBF: Menjaga Momentum Pemulihan Untuk Membangun Bangsa Yang Lebih Sehat. www.kalbe.co.id; 2022.
  9. Kalbe Farma. Company Update Audited FY22. Presented at: Riding the Recovery to Build a Healthier Nation; 2023.
  10. Algustie AK, Dharmmesta BS. Analisis Strategi Bisnis PT Soho Industri Farmasi Regular. Jurnal Manajemen dan Pelayanan Farmasi. 2012;2(4):231-238.
  11. Smith B, Jambulingam T. Entrepreneurial orientation: Its importance and performance as a driver of customer orientation and company effectiveness among retail pharmacies. IJPHM. 2018;12(2):158-180. doi:10.1108/IJPHM-07-2017-0038
  12. Officer T, Cumming J, McBride-Henry K. Successfully developing advanced practitioner roles: policy and practice mechanisms. JHOM. 2019;33(1):63-77. doi:10.1108/JHOM-02-2018-0064
  13. Presiden Republik Indonesia. Undang-Undang Republik Indonesia Nomor 40 Tahun 2007 Tentang Perseroan Terbatas.; 2007.
  14. David FR, David FR. Strategic Management - Concepts and Cases - A Competitive Advantage Approach. Sixteenth Edition. Pearson; 2017.
  15. PT Kimia Farma Tbk. Laporan Tahunan 2022 Annual Report KAEF: Berdiri Teguh, Memelopori Kesehatan Masa Depan. www.kimiafarma.co.id; 2022.
  16. PT Darya-Varia Laboratoria Tbk. Laporan Tahunan 2022 Annual Report DVLA: Greatness and Beyond (Bigger-Bolder-Braver). www.darya-varia.com; 2022.
  17. PT Phapros Tbk. Laporan Tahunan 2022 Annual Report PEHA: Raising Performance and Sustainability. www.phapros.co.id; 2022.
  18. PT Merck Tbk. Laporan Tahunan 2022 Annual Report MERK: Bring Impact. www.merckgroup.com; 2022.
  19. Paramita A, Kristiana L. Focus Group Discussion Tehnique in Qualitative Research. Buletin Penelitian Sistem Kesehatan. 2013;16(2):117-127.
  20. Barrett D, Heale R. What are Delphi studies? Evidence-Based Nursing. 2020;23(3):68-69. doi:10.1136/ebnurs-2020-103303
  21. Nasution HJ, Tarigan JK, Dalimunthe A, Nurlinda. Analisis Boston Consulting Group (BCG) pada PT Industri Jamu dan Farmasi Sido Muncul Tbk. Polimedia. 2021;24(1).
  22. Suwito FA, Jannah N. Analisis Pangsa Pasar Dengan Metode BCG Matriks Pada Perusahaan Farmasi Di Bursa Efek Indonesia. Jurnal Ilmiah Manajemen, Ekonomi Bisnis, Kewirausahaan. 2023;10(2).
  23. Umar A, Sasongko AH, Aguzman G, Sugiharto. Strategi Pengembangan Bisnis pada Bisnis Pariwisata. Jurnal Ekonomi. 2016;7(2).
  24. Kim WC, Mauborgne R. Three avenues of innovation for new market creation and growth. Strategy and Leadership. 2023;51(5):11-15. doi:10.1108/SL-07-2023-0071



DOI: https://doi.org/10.22146/jmpf.85958

Article Metrics

Abstract views : 4021 | views : 6338

Refbacks

  • There are currently no refbacks.


Copyright (c) 2023 JURNAL MANAJEMEN DAN PELAYANAN FARMASI (Journal of Management and Pharmacy Practice)

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

©Jurnal Manajemen dan Pelayanan Farmasi
Faculty of Pharmacy
Universitas Gadjah Mada
Creative Commons License
View My Stats